Literature DB >> 28881385

Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.

Z Powis1, K D Farwell Hagman2, C Mroske2, K McWalter3, J S Cohen4, R Colombo5,6, A Serretti7, A Fatemi4,8, K L David9, J Reynolds10, L Immken11, H Nagakura11, C M Cunniff12, K Payne13, T Barbaro-Dieber14, K W Gripp14, L Baker15, T Stamper16, K A Aleck17, E S Jordan18, J H Hersh18, J Burton19, I M Wentzensen3, M J Guillen Sacoto3, R Willaert3, M T Cho3, I Petrik2, R Huether2, S Tang2.   

Abstract

Diagnostic exome sequencing (DES) has aided delineation of the phenotypic spectrum of rare genetic etiologies of intellectual disability (ID). A SET domain containing 5 gene (SETD5) phenotype of ID and dysmorphic features has been previously described in relation to patients with 3p25.3 deletions and in a few individuals with de novo sequence alterations. Herein, we present additional patients with pathogenic SETD5 sequence alterations. The majority of patients in this cohort and previously reported have developmental delay, behavioral/psychiatric issues, and variable hand and skeletal abnormalities. We also present an apparently unaffected carrier mother of an affected individual and a carrier mother with normal intelligence and affected twin sons. We suggest that the phenotype of SETD5 is more complex and variable than previously presented. Therefore, many features and presentations need to be considered when evaluating a patient for SETD5 alterations through DES.
© 2017 The Authors. Clinical Genetics published by John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SETD5; exome sequencing; haploinsufficiency; intellectual disability

Mesh:

Substances:

Year:  2018        PMID: 28881385     DOI: 10.1111/cge.13132

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Transcription Pause and Escape in Neurodevelopmental Disorders.

Authors:  Kristel N Eigenhuis; Hedda B Somsen; Debbie L C van den Berg
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

Review 2.  Epigenetic disorders: Lessons from the animals-animal models in chromatinopathies.

Authors:  Elisabetta Di Fede; Paolo Grazioli; Antonella Lettieri; Chiara Parodi; Silvia Castiglioni; Esi Taci; Elisa Adele Colombo; Silvia Ancona; Alberto Priori; Cristina Gervasini; Valentina Massa
Journal:  Front Cell Dev Biol       Date:  2022-09-26

3.  Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental gene expression and cognition.

Authors:  Elena Deliu; Niccolò Arecco; Jasmin Morandell; Christoph P Dotter; Ximena Contreras; Charles Girardot; Eva-Lotta Käsper; Alena Kozlova; Kasumi Kishi; Ilaria Chiaradia; Kyung-Min Noh; Gaia Novarino
Journal:  Nat Neurosci       Date:  2018-11-19       Impact factor: 28.771

4.  The Autism-Related Protein SETD5 Controls Neural Cell Proliferation through Epigenetic Regulation of rDNA Expression.

Authors:  Tadashi Nakagawa; Satoko Hattori; Risa Nobuta; Ryuichi Kimura; Makiko Nakagawa; Masaki Matsumoto; Yuko Nagasawa; Ryo Funayama; Tsuyoshi Miyakawa; Toshifumi Inada; Noriko Osumi; Keiichi I Nakayama; Keiko Nakayama
Journal:  iScience       Date:  2020-04-06

5.  Setd5 is required in cardiopharyngeal mesoderm for heart development and its haploinsufficiency is associated with outflow tract defects in mouse.

Authors:  Michelle Yu-Qing Cheung; Catherine Roberts; Peter Scambler; Athanasia Stathopoulou
Journal:  Genesis       Date:  2021-05-29       Impact factor: 2.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.